Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months

Obesity Surgery

Volumn 15, Issue 10, 2005, Pages 1418-1423

  Keshishian, Ara ^a,b   Zahriya, Karim ^a   Willes, Edric B ^a  

^a Delano Regional Medical Center   (United States)

^b NONE   (United States)

Author keywords

Biliopancreatic diversion and duodenal switch; Hepatic function; Morbid obesity; Nonalcoholic hepatic steatosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DUODENUM; FEMALE; HEPATITIS; HUMAN; LIVER BIOPSY; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BARIATRIC SURGERY; BILIOPANCREATIC DIVERSION; FATTY LIVER; FEMALE; HEPATITIS; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; OBESITY, MORBID; RETROSPECTIVE STUDIES;

EID: 28544448787     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089205774859290     Document Type: Article

References (15)

1. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121: 91-100.
2. Moretto M, Kupski C, Mottin CC et al. Hepatic steatosis in patients undergoing bariatric surgery and its relationship to body mass index and co-morbidities. Obes Surg 2003; 13: 622-4.
3. Srivastava S, Younossi, ZM. Morbid obesity, nonalcoholic fatty liver disease, and weight loss surgery. Hepatology 2005; 42: 490-2.
4. Papadia FS, Marinari GS, Camerini G et al. Liver damage in severely obese patients: a clinical biochemical-morphologic study on 1,000 liver biopsies. Obes Surg 2004; 14: 952-8.
5. Wolf AM, Busch B, Kuhlmann HW et al. Histological changes in the liver of morbidly obese patients: correlation with metabolic parameters. Obes Surg 2005; 15: 228-37.
6. Baltasar A, Bou R, Bengochea M et al. Duodenal switch: an effective therapy for morbid obesity - intermediate results. Obes Surg 2001; 11: 54-8.
7. Shalhub S, Parsee A, Gallagher SF et al. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients. Obes Surg 2004; 14: 54-9.
8. Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg 1998; 8: 267-82.
9. Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg 2005; 15: 408-16.
10. Keshishian A, Zahriya K, Hartoonian T et al. Duodenal switch is a safe operation for patients who have failed other bariatric operations. Obes Surg 2004; 14: 1187-92.
11. Papadia F, Marinari GM, Camerini C et al. Short-term liver function after biliopancreatic diversion. Obes Surg 2003; 13: 752-5.
12. Baltasar A, Serra C, Perez N et al. Clinical hepatic impairment after the duodenal switch. Obes Surg 2004; 14: 77-83.
13. Van Hee RH. Biliopancreatic diversion in the surgical treatment of morbid obesity. World J Surg 2004; 28: 435-44.
14. Keshishian A, Zahriya K. Stapled Roux-en-Y anastomosis: an illustrated technique. Obes Surg 2003; 13: 450-2.
15. Bloomberg RD, Fleishman A, Nalle JE et al. Nutritional deficiencies following bariatric surgery: what have we learned? Obes Surg 2005; 15: 145-54.